Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Organisation › Details

Acesion Pharma ApS

Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. Existing drug therapies generally have a limited effect or are associated with risk of serious adverse events, and there is therefore a considerable patient need for developing better and safer drugs. Inhibition of SK channels, an ion channel with relevance for regulating the heart rhythm, constitute a new and promising principle for the treatment of AF. Acesion Pharma aims to develop first-in-class SK channel inhibitors as a more efficacious and safer treatment of AF. Main equity investors in Acesion Pharma are Novo A/S, Wellcome Trust, Broadview Ventures and SEED Capital. *

 

Period Start 2011-12-15 splitoff (date ca.)
  Predecessor NeuroSearch A/S (CSE: NEUR)
Product Industry cardiovascular drug
Persons Person Wuite, Frans (Acesion Pharma 201604– CEO before Oncos Therapeutics + Amgen + Warren & Araim Pharma)
  Person 2 Sørensen, Ulrik S. (Acesion Pharma 201604– COO before CEO before NeuroSearch)
     
Region Region København (Copenhagen)
  Country Denmark
  Street 3 Ole Maaløes Vej
  City 2200 Copenhagen N
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: 
     
   
Record changed: 2024-02-12

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top